Traversal from G1 to S-phase in cycling cells of budding yeast is dependent on the destruction of the S-phase cyclin/CDK inhibitor SICL. Genetic data suggest that SIC1 proteolysis is mediated by the ubiquitin pathway and requires the action of CDC34, CDC4, CDC53, SKP1, and CLN/CDC28. As a first step in defining the functions of the corresponding gene products, we have reconstituted SICi multiubiquitination in DEAEfractionated yeast extract. Multiubiquitination depends on cyclin/CDC28 protein kinase and the CDC34 ubiquitin-conjugating enzyme. Ubiquitin chain formation is abrogated in cdc4t8 mutant extracts and assembly restored by the addition of exogenous CDC4, suggesting a direct role for this protein in SICi multiubiquitination. Deletion analysis of SICi indicates that the N-terminal 160 residues are both necessary and sufficient to serve as substrate for CDC34-dependent ubiquitination. The complementary C-terminal segment of SICi binds to the S-phase cyclin CLB5, indicating a modular structure for SICL.
INTRODUCTION
The transition from G1 to S-phase in the budding yeast cell cycle requires several genetic functions, including CDC4, CDC34, CDC53, SKP1, one member of the family of G1 cyclins (CLN1-CLN3), and one member of the family of S-phase-promoting B-type cyclins (CLB1-CLB6) (Goebl et al., 1988; Schwob et al., 1994; Bai et al., 1996; Mathias et al., 1996; Schneider et al., 1996) . An elegant genetic model that accounts for the functions of these genes in the progression from G1 to S-phase was put forward by Schwob et al. (1994) . They observed that at the nonpermissive temperature in cdc34ts, cdc4ts, and cdc53ts mutant cells, the activity of the S-phase-promoting CLB/CDC28 protein kinase is repressed by high levels of the CDK inhibitor SIC1 (Mendenhall, 1993; Nugroho and Mendenhall, 1994) . Normally, SIC1 is degraded as wild-type cells negotiate the G1-S transition (Donovan et al., 1994; Schwob et al., 1994) . Cell cycle-regulated destruction of SIC1 fails to occur, however, in cdc4ts, cdc34ts, and cdc53ts mutants. Moreover, accumulation of SIC1 is required for the G1 arrest phenotype of these mutants, as deletion of SIC1 allows DNA replication to proceed in each of these mutants (Schwob et al., 1994) . These observa-* Corresponding author.
tions suggest that CDC34, CDC4, and CDC53 promote the cell cycle-regulated destruction of SIC1, thereby revealing the heretofore cryptic S-phase-promoting protein kinase activity of CLB/CDC28. More recent work has established that SKP1, like CDC4, CDC53, and CDC34, is also required for SIC1 destruction and DNA replication, and the S-phase defect imposed by certain skplts mutant alleles can be rescued by deletion of SIC1 (Bai et al., 1996) . Elimination of SIC1 also appears to be a crucial aspect of CLN function during G1 phase. Clearance of accumulated SIC1 and initiation of DNA replication upon reversal of the cdc34ts block requires CLN function (Schneider et al., 1996) , and cells lacking SIC1 no longer require CLN activity for timely initiation of S-phase (Dirick et al., 1995) or for viability (Schneider et al., 1996; Tyers, 1996) .
The proposal that CDC34 promotes SIC1 degradation at the G1-S transition has considerable appeal, because CDC34 encodes a member of the ubiquitinconjugating enzyme family (Goebl et al., 1988) . Other members of this family of proteins have previously been implicated in the degradation of unstable proteins (Hochstrasser, 1995) via the ubiquitin-proteasome pathway. Ubiquitin, a small highly conserved protein, is first activated at its C terminus by forming a thioester bond with an El enzyme. Ubiquitin is subsequently transesterified to a ubiquitin-conjugat-ing (E2) enzyme like CDC34. Finally, ubiquitin is transferred from the E2 to a lysine residue of the target protein, either directly or with the assistance of a ubiquitin protein ligase (E3). Multiple cycles of ubiquitin transfer result in the assembly of a multiubiquitin chain on the substrate, which, in turn, targets it to the 26S proteasome, where it is degraded. Although the genetic data suggest that SIC1 might be the key S-phase-inhibiting substrate of CDC34, it has not been demonstrated if SIC1 is in fact ubiquitinated and if CDC34 is required for its ubiquitination.
Although the sequence of CDC34 suggests that it may promote degradation of SIC1 via the ubiquitin pathway, it is unclear if CLNs, CDC4, CDC53, and SKP1 contribute directly to this process. For instance, the requirement for CLN/CDC28 kinase may be direct, involving phosphorylation of either SIC1 or the components of the ubiquitination machinery. It is equally possible that CLN/CDC28 promotes the synthesis of Gl-specific mRNA transcripts that encode proteins involved in SIC1 turnover (Marini and Reed, 1992; Koch et al., 1996) . Furthermore, the sequences of CDC4, CDC53, and SKP1 are not homologous to El, E2, or E3 components of known ubiquitin-dependent proteolytic pathways, thereby raising the question as to what their exact function is. Both CDC53 and SKP1 are members of novel gene families that are conserved in Saccharomyces cerevisiae, Caenorhabditis elegans, and humans (Zhang et al., 1995; Bai et al., 1996; Kipreos et al., 1996; Mathias et al., 1996) . CDC4 contains two recognizable sequence motifs: an SKPl-binding domain termed the "F-box" and eight copies of the WD-40 repeat (Neer et al., 1994; Bai et al., 1996) . Genetic data suggest that the products of CDC4, CDC53, CDC34, and SKP1 interact (Bai et al., 1996; Mathias et al., 1996) . This prediction has, in part, been confirmed by the assembly of CDC4/SKP1 (Bai et al., 1996) and CDC53/CDC34 (Willems et al., 1996) complexes with recombinant proteins and by the enrichment of CDC4 and CDC53 in affinity-purified preparations of CDC34 (Mathias et al., 1996) . Though these interactions are intriguing, it remains unclear whether CDC4, CDC53, and SKP1 participate directly with CDC34 in the ubiquitination of substrates or function in a downstream process such as guiding ubiquitinated substrates to the proteasome.
In the present study, we use DEAE-fractionated yeast extract to demonstrate that SIC1 is efficiently multiubiquitinated in vitro, resulting in at least 85% of the input protein being converted to high molecular weight ubiquitin conjugates. We observe a complete dependence on CLN/CDC28 kinase and CDC34 for high molecular weight ubiquitin conjugate formation. SIC1 accumulates as a phosphoprotein in the absence of CDC34 function and as an unmodified protein in the absence of kinase, suggesting that phosphorylation may precede ubiquitination. The in vitro ubiquitination assay also revealed a potential ubiquitin ligaselike function for the CDC4 gene product. Deletion analysis of SIC1 was carried out to map sequence elements that target it for destruction. This analysis revealed the existence of a ubiquitination determinant in the N terminus of SIC1 between residues 28 and 37. The C-terminal amino acids 160-284 were dispensible for ubiquitination but were required for binding CLB5/CDC28, the S-phase kinase that is activated upon SIC1 destruction. RJD885 (ura3, leu2, trpl, cln1 ::URA3, cln2::LEU2, cln3::URA3, leu2::GAL-CLN3::LEU2, pep4::TRPI, cdc28::CDC28HA::HIS3, MATa) and RJD893 (ura3, his3, trpl, clnl::URA3, cln2::LEU2, cln3::URA3, leu2::GAL-CLN3::LEU2, cdc4, pep4::TRPI, cdc28::CDC28,itusp;HA:.HIS3, MATa) cells grown in 2 1 of YEP-2% galactose were transferred by centrifugation to 2 1 of YEP-2% glucose and incubated for 5.5 h at 24°C to deplete CLN3. Depleted cells were harvested at 4°C, washed once with 200 ml of ice-cold water, and extruded as cell paste into liquid N2. Frozen cells (3.5 g) were ground in a liquid N2-chilled mortar for 10 min, and frozen powder was thawed on ice in 0.5 volumes of B93 [30 mM HEPES, pH 7.2, 100 mM potassium acetate, 1 mM EDTA, 1 mM MgCl2, 10% glycerol, 2 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride (PMSF)I fortified with an additional 200 mM potassium acetate. Once thawing was complete, extract was incubated on ice for 15 min, centrifuged (15 min, 50,000 rpm, Sorvall RP100-AT4) to yield an S135 (135,000 x g) fraction, and frozen in liquid N2. S135 (30-45 mg/ml) was thawed; adjusted to 2 mM magnesium acetate, 2 mM CaCl2, 10 ,g/ml RNase, 20 ,ug/ml DNase, 900 mU/ml hexokinase, and 50 mM glucose; incubated for 30 min at 16°C; and dialyzed once against 1 1 of CWB (CWB is 25 mM HEPES, pH 7.6, 25 mM NaCl; the dialysis step can be omitted with no detrimental effect). After sedimenting insoluble protein (10 min at 135,000 x g), 96 mg of protein was diluted to 25 ml with CWB and applied to a 5-ml column of DEAE-Sepharose FF. The column was washed consecutively with 2 column volumes of CWB, CWB plus 50 mM NaCl, CWB plus 225 mM NaCl, and CWB plus 500 mM NaCl. Proteins eluting at 250 mM NaCl were concentrated by precipitation with (NH4)2SO4 (80% saturation) or by centrifugal filtration in a Centriprep-10 (Amicon, Beverly, MA), resuspended in 0.75 ml of B93, and dialyzed once against 1 1 of B93. Insoluble protein was pelleted by centrifugation (10 min at 135,000 x g), and the supernatant (35 mg of protein in 1.0 ml; 0.25 M DEAE fraction) was frozen in liquid N2 and stored at -80°C. Fractionation of CDC34 on the DEAE column was monitored by immunoblotting column fractions with anti-CDC34 antiserum (kindly provided by V. Chau, Wayne State Univ.). The 250 mM NaCl eluate was essentially devoid of CDC34, which eluted at 500 mM NaCl. Although the bulk of free ubiquitin flowed through, the 0.25 M DEAE fraction still contained ubiquitin, as determined by immunoblotting.
MATERIALS AND METHODS Preparation of Fractionated Yeast Extract

Ubiquitination Reactions
Unless otherwise indicated, ubiquitination reactions contained 100 ,ug of 0.25 M DEAE fraction, 1 ,ul of crude or 2 ,gl of DEAEfractionated reticulocyte or wheat germ translation reaction containing SICL, 10 ,ug of ubiquitin, 100 ng of CDC34, 100 ng of glutathionine S-transferase (GST)-CLN2, and an ATP-regenerating system (ARS; . Final concentrations of salts and other compounds were 20 mM HEPES, pH 7.2, 100 mM potassium acetate, 6 mM magnesium acetate, 0.5 mM MgCl2, 2 mM DTT, 5% glycerol, 0.5 mM PMSF, 0.5 mM EDTA, 5 ,g/ml pepstatin, and 5 ,ug/ml leupeptin. Reactions were incubated at 25°C for the indi-SIC1 Ubiquitination cated times and processed for SDS-PAGE and fluorography as described . Ubiquitin was obtained from Sigma (St. Louis, MO), and GST-CLB2 (Kellogg et al., 1995) , GST-CLN2 , CDC34 (Banerjee et al., 1993) and K48R-His6-ubiquitin (Beers and Callis, 1993) were purified from Escherichia coli as described. Methyl-ubiquitin was kindly provided by R. King (Harvard Medical School), and purified UBC4 and RAD6 were kindly provided by V. Chau. Preparation of SIC1 Substrates SIC1 coding sequences from pMDM169 (Nugroho and Mendenhall, 1994) were excised as a BamHI-PstI fragment and inserted into BamHI plus PstI-digested pGEM1, yielding pRD112. SIC1 produced by transcription/translation of SIC1 coding sequences as described uitination assays (our unpublished observations). SIC1 transcription templates with 5' or 3' terminal deletions were prepared using a PCR method as described (Verma et al., 1997) . The oligonucleotides used to create the indicated deletions are shown below. To generate 5' truncations, the AN18, AN27, AN37, AN76, and AN158 oligonucleotides were used in conjunction with NotI 3'. The number following A refers to the number of codons deleted from the 5' end (e.g., AN37 lacks amino acids 1-37): NotI 3', gcgggatcctcaatgcggccgctcttgatccctagattg; AN18, gggttaatacgactcactataggatccatgagtggcaatactagttctagtg; AN27, gggttaatacgactcactataagatctcatatgcaaggtcaaaagacccc; AN37, gggttaatacgactcactataggatccatgtcacagaacctagtccctgtc; AN76, gggttaatacgactcactataagatctcatatgcctcaacgctcgccgtttcc; and AN158, cccttaatacgactcactataggatccatatggatcagacacatagaaagaag.
The NotI 3' oligonucleotide changes the sequence of the C terminus of SIC1 from DQEH to DQERPH. This change did not affect the ubiquitination of SIC1 (our unpublished results).
To generate 3' truncations, the AC24, AC74, AC98, AC125, AC155, and AC179 oligonucleotides were used in conjunction with WT 5'. The number following A refers to the number of codons deleted from the 3' end (e.g., AC24 lacks amino acids 261-284): WT 5', cccgaattcttaatacgactcactataagatctcatatgactccttccacccc; AC24, ggggatcctcatttctctaccacctctcccttc; AC74, ggggatcctcaattgatgatgatgtcttcctcg; AC98, ggggatcctcaattttttgccaattcaaatg; AC125, ggggatcctcaatcaaactcatctctttcaagtg; AC155, ggggatcctcattctgctgcatctatatccac; and AC179, ggggatccctactcttcccttactgttcc.
Alkaline Phosphatase Treatment of SICi
A 10-,ul in vitro ubiquitination reaction lacking CDC34 and containing 2 ,ll of reticulocyte-translated SIC1mYC-Hi was diluted with 190 ,ul of IPB (IPB; 25 mM Tris, pH 7.5, 0.1% Nonidet P-40, 100 mM Vol. 8, August 1997 NaCl, 1 mM EDTA, 2 mM DTT, 0.1 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochlorine (AEBSF), 1 mM PMSF, 2.5 ,ug/ml pepstatin, 2.5 ,tg/ml leupeptin), supplemented with 1 j,l of 9E10 ascites fluid (Evan et al., 1985) and incubated for 45 min at 4°C.
Immune complexes retrieved by incubation with anti-mouse IgGl Sepharose beads (Sigma; 15,ul, packed volume) were washed twice with IPB and twice with 50 mM Tris, pH 8.8. Washed beads were resuspended in 50 mM Tris, pH 8.8, treated with 20 U alkaline phosphatase in the presence or absence of 100 mM sodium phosphate, pH 8.8, at 37°C for 15 min, and processed for SDS-PAGE and autoradiography .
Baculovirus Expression of CDC4 in Insect Cells
To generate a recombinant baculovirus expressing CDC4, the fulllength CDC4 gene contained in the plasmid pCDC4-73 (kindly provided by B. Jensen, University of Washington, Seattle, WA) was amplified by PCR using oligonucleotides RDO 72 (GAACGACTAG-TACCATGGGGTCGTTTCCCTTAGC) and RDO 73 (GAACGGTC-GACTCATGGTATTATAGTTGTCC). The resulting product was digested with SpeI plus Sall and ligated into pRS306 that had been digested with XbaI plus Sall. The PCR-derived part of CDC4 was checked by DNA sequencing. The recombinant plasmid was digested with XhoI, treated with Klenow fragment, digested with EagI, and ligated into the baculovirus transfer vector pVL1392 that had been digested with EagI and SmaI. The resulting transfer vector was mixed with BaculoGold viral DNA (PharMingen, San Diego, CA) and transfected into Sf9 insect cells. Plaques expressing CDC4 as assayed by Western blot analysis were purified and amplified in Sf9 cells.
Cell lysates were prepared by infecting 100-mm dishes containing 107 Sf9 cells with virus at a multiplicity of infection of 10. After 43 h, cells were harvested, washed twice with Tris-buffered saline, pH 7.5, resuspended in 1 ml of ice-cold BVL buffer (20 mM HEPES-KOH, pH 7.2,150 mM NaCl, 0.1% Triton X-100, 5 mM MgC12, 5 mM EDTA, 2 mM DTT, 1 mM PMSF, 2 jig/ml leupeptin, 2 ,ug/ml pepstatin), and sonicated briefly to ensure lysis. After pelleting cell debris (15 min at 13,000 x g), the lysate was dialyzed twice for 2 h against 1 1 of buffer B93. The dialysate was clarified by centrifugation (10 min at 13,000 x g) and stored at -80°C. Cell lysates contained approximately 4 mg/ml total protein, approximately 0.25% of which was CDC4.
Binding of SIC1 to CLB5
Congenic strains K3819 (RJD916; ade2-1, trpl-1, canl-100, leu2-3,-112, his3-11,-15, ura3 ::ADH-HA-CLB5::URA3, MATa) and W303 (RJD360; canl-100, leu2-3,-112, his3-11,-15, trpl-1, ura3-1, ade2-1, MATa) were grown in YEPD medium, and cell extracts (5 mg protein/ml) were prepared by agitation with glass beads in cell lysis buffer (25 mM Tris, pH 7.5,100 mM NaCl, 0.1% Nonidet P-40, 5 mM EDTA, 1 mM EGTA, 2 mM sodium vanadate, 60 mM l3-glycerophosphate, 2 mM DYT, 10 mM NaF, 0.5 mM PMSF, 2 ,tg/ml aprotinin, 2 ,ug/ml leupeptin, 2 ,ug/ml pepstatin). Each binding reaction contained 200 ,ul (1 mg) of yeast extract, 1 ,ul of anti-HA ascites fluid, and 2 ,ul of "normalized" wheat germ translation product (translation products were adjusted to similar concentrations by dilution with an unprogrammed wheat germ translation reaction). Following a 60-min incubation on ice, immune complexes were collected on a protein A matrix, washed three times with cell lysis buffer, and analyzed by SDS-PAGE and fluorography. Extract from cells arrested in G1 due to CLN deplel tionated by chromatography on DEAE resin and with ubiquitin (Ub), CDC34, GST-CLN2, and ARS. "5, synthesized in reticulocyte lysate and fractionated b matography on DEAE was added and the reaction 25°C for the indicated lengths of time. Reactions we and samples were resolved by SDS-PAGE and proce radiography as described Figure 1A Sy batch chro-Methylation of the E-amino group of lysines or mutaincubated at tion of lysine 48 in ubiquitin (Ub) blocks multiubiqMre terminated uitin chain formation by preventing Ub-Ub ligation ssed for auto- (Hershko and Heller, 1985; Chau et al., 1989) . In sum, Conversion of the data in Figure 1 demonstrate that multiubiquitinaabsence (lane tion of SIC1 in fractionated yeast extract was rapid, on containing efficient, and highly processive. Indeed, the CDC34-I in lanes 2 (10 dependent accumulation of multiubiquitinated SIC1 ented with the was severalfold more rapid and 5-to 10-fold more ubdiqfuitimn t(h5 efficient than what is observed using CLN2 as a subs 7 and 8, as strate Verma et al., 1997) . DEAE-fractionated extract (xtr) from wild-type CDC4+ (lane 2) or cdc4ts (lanes 3-9) cells; yeast extract was absent in lanes 1, 10, and 11. Lanes 4 and 5 contain cell lysate from uninfected Sf9 cells; lanes 6 and 7 contain lysate from Xenopus CDC2-expressing Sf9 cells; and lanes 8-11 contain lysate from CDC4-expressing Sf9 cells. Lanes 5, 7, and 9 contain a 1:3 dilution of the corresponding Sf9 cell lysate from lanes 4, 6, and 8, respectively. Reactions were carried out and processed as described in Figure 1A .
RESULTS
Reconstitution of SIC1 Ubiquitination in
nated species was produced upon incubation of SIC1 in unfractionated cell extract (our unpublished results). For the remainder of the experiments, we used fractionated cell extracts, however, as they were both more active for SIC1 ubiquitination and more versatile due to their dependence on CDC34 (see below).
Ubiquitination of SIC1 Requires CDC34 and CDC4
The disappearance of SIC1 at the G1-S transition in vivo requires the activity of the ubiquitin conjugating enzyme encoded by CDC34 (Schwob et al., 1994) . Presumably due to its highly acidic C-terminal tail (Goebl et al., 1988) 2), the 0.25 M DEAE fraction isolated from cdc4ts cells failed to sustain the assembly of high molecular mass SICl-ubiquitin conjugates (lane 3). This ubiquitination defect was specific, since addition of Sf9 insect cell lysates containing CDC4 expressed from a recombinant baculovirus restored SIC1 ubiquitination (lanes 8 and 9), whereas Sf9 lysates from uninfected cells (lanes 4 and 5) or from cells infected with a Xenopus CDC2-expressing baculovirus (lanes 6 and 7) had no effect. Estimates of the CDC4 concentration in Sf9 lysates (via immunoblotting) indicated that efficient rescue of cdc4ts extract was achieved with 1-10 nM CDC4 (our unpublished observations).
Phosphorylation and Ubiquitination of SIC1
Require CLN2
Genetic studies indicate that continuous CLN expression is needed for SIC1 turnover in cells released from a cdc34t's conditional block (Schneider et al., 1996) . Additionally, cells with deleted CLNs can be rescued by deleting SICI, implying that CLN-dependent inactivation of SIC1 is rate-limiting for entry into S-phase and cell growth (Dirick et al., 1995; Schneider et al., 1996; Tyers, 1996) . To test whether CLN/CDC28 protein kinase activity is directly required for multiubiquitination of SIC1, we assembled ubiquitination reactions lacking exogenously added GST-CLN2. Since the 0.25 M DEAE fraction was prepared from Gl-arrested cyclin-depleted cells, it contained little or no CDC28-associated protein kinase activity . Upon addition of GST-CLN2 or GST-CLB2, however, the 0.25 M DEAE fraction generated CDC28-associated protein kinase activity, as was reported for unfractionated extracts  our unpublished observations).
Whereas SIC1 was efficiently ubiquitinated in 0.25 M DEAE fraction supplemented with GST-CLN2 or GST-CLB2 ( Figure 3A , lanes 2 and 4), neither ubiquitination nor the 2-kDa shift in molecular mass were observed when cyclin was omitted from the reaction ( Figure 3A, lane 3) . Similarly, SIC1 ubiquitination and the 2-kDa shift in molecular mass were significantly reduced in reactions performed with extract prepared from G1-arrested cdc28ts cells (our unpublished results). The cyclin-dependent 2-kDa shift in molecular mass was due to phosphorylation of SIC1, since the "shifted" 42-kDa form of epitope-tagged SIC1 (SIClmYcHis6) that accumulated in reactions containing GST-CLN2 but lacking CDC34 ( Figure 3B , lane 3) was converted to the 40-kDa form upon incubation with alkaline phosphatase ( Figure 3B , lane 5). This 2-kDa shift in molecular weight most likely arises from direct phosphorylation of SIC1 by CDC28, since CLN2/ CDC28 complexes immunoisolated from yeast cells can phosphorylate purified bacterially expressed SIC1 (Schwob et al., 1994; our ( Donovan et al., 1994; Schwob et al., 1994; Schneider et al., 1996) .
The N-Terminal Domain of SIC1 Contains a Ubiquitination Determinant
To begin an analysis of how the CDC34 pathway selects SIC1 as a substrate for ubiquitination, we constructed a series of 5' and 3' truncations of SICI by PCR. PCR templates were transcribed and translated in vitro, and the amount of protein translated from each template was estimated by quantitation of SDSpolyacrylamide gels. Equivalent amounts of wild-type and mutant proteins were mixed with fully supplemented 0.25 M DEAE fraction and incubated under standard reaction conditions. Whereas wild-type SIC1 yielded a characteristic pattern of ubiquitin conjugates ( Figure 4A , lane 2), a mutant lacking the first 37 amino acids was a poor substrate (lane 6), suggesting that the N terminus of SIC1 contains a determinant that is essential for its recognition by the CDC34 pathway. Since a truncation mutant lacking the first 27 amino acids was only mildly defective for ubiquitination (our unpublished results), the determinant could be narrowed down to residues 28 through 37. A complementary set of C-terminal deletions was generated to test whether the N-terminal domain of SIC1 was sufficient to serve as a substrate for CDC34-dependent ubiquitination. Deletion of as many as 125 residues from the C terminus of SIC1 had only a modest effect on ubiquitination (AC125 mutant; Figure  4B , lanes 10-12), which remained dependent upon CDC34 and CLN2 (our unpublished data). In contrast, removal of 30 more amino acids compromised the ability of SIC1 to serve as a substrate for ubiquitination (AC155, lanes 13-15). Nevertheless, a deletion mutant retaining only the first 105 amino acids of SIC1 was still ubiquitinated in vitro (AC179, lanes 16-18) in a reaction that remained dependent on the addition of GST-CLN2 (lanes 20 and 21) . The diminished ubiquitination of the AC155 and AC179 mutants correlated with a reduced phosphorylation-dependent mobility shift. Since the 30 amino acid segment between amino acids 130 and 160 does not contain any consensus sites for CDC28-dependent phosphorylation, it is unclear if this region contains a binding site required for interaction with CLN2/CDC28 or is required for proper folding of the N-terminal domain.
Ubiquitination of SIC1 Does Not Depend upon Its
Association with CLB5ICDC28
The same truncation mutants that were used to map ubiquitination determinants in SIC1 were also tested for their ability to bind to CLB5/CDC28 complexes. Wheat germ lysates containing in vitro-translated
[35S]methionine-labeled wild-type or mutant SIC1 proteins were mixed with either control yeast extract or yeast extract containing hemagglutinin-tagged CLB5 (CLB5HA). CLB5HA and associated proteins were then retrieved by immunoprecipitation with an anti-hemagglutinin monoclonal antibody (anti-HA), and the immune complexes were evaluated by SDS-PAGE and fluorography ( Figure 5 ). Whereas SIC1 mutants lacking as few as 37 residues from the N terminus were poor substrates for the CDC34 pathway ( Figure 4A , lane 6), deletion of up to 160 residues from the N terminus had no effect on the interaction between SIC1 and CLB5HA (Figure 5 bottom, lanes 7-9) .
In contrast, deletion of 24 residues from the C termi- plates were incubated with extract from yeast cells expressing either untagged or HA-tagged CLB5. CLB5HA-associated proteins were retrieved by immunoprecipitation with anti-HA monoclonal antibody 12CA5 and detected by SDS-PAGE followed by autoradiography. I refers to the input fraction, B refers to the bound fraction from reactions containing CLB5HA extract, and C refers to the bound fraction from reactions containing untagged CLB5 extract. In each set of lanes, the antibody-enriched fractions B and C were overloaded twofold with respect to the input fraction. Top, Cterminal truncation mutants deleted for the indicated number of amino acids from the C terminus (e.g., AC24 lacks amino acids 261-284). Bottom, N-terminal truncation mutants deleted for the indicated number of amino acids from the N terminus (e.g., AN 76 lacks amino acids 1-76).
nus of SIC1 (AC24) inactivated its ability to bind CLB5HA ( Figure 5 top, lanes 3 and 4) but had little or no effect on SIC1 ubiquitination ( Figure 4B , lane 6).
DISCUSSION
We report herein the reconstitution of SIC1 ubiquitination in extracts from budding yeast cells. Assembly of multiubiquitin chains on SIC1 in vitro required the E2 enzyme CDC34, a potential E3 subunit known as CDC4, and cyclin-dependent protein kinase activity. The N-terminal domain of SIC1 was both necessary and sufficient to direct CDC34-and cyclin-dependent ubiquitination of SIC1. In contrast, the C-terminal domain mediated the association of SIC1 with CLB5/ CDC28.
Factors Required for SIC1 Ubiquitination Previously, it had been shown in vivo that cdc4ts, cdC34ts, cdc53ts, skplts, and CLN-deficient mutants fail to initiate both S-phase and SIC1 proteolysis (Goebl et al., 1988; Schwob et al., 1994; Bai et al., 1996; Mathias et al., 1996; Schneider et al., 1996) . Given that deletion of SICI relieves the S-phase block in these mutants, it was proposed that CDC34, CDC4, CDC53, SKP1, and CLNs promote the initiation of DNA replication by specifying the elimination of SIC1 (Schwob et al., 1994) . The results presented herein provide strong support for this model and suggest that CDC4 and CDC34 promote SIC1 degradation by directly catalyzing the assembly of multiubiquitin chains upon SIC1. The results also prompt the question of whether CDC53 and SKP1 are required for SIC1 multiubiquitination. Although cdc53ts mutant extracts were defective for SIC1 ubiquitination, we were unable to rescue them with Sf9 insect cell lysates containing CDC53 expressed from a recombinant baculovirus. We did not test skpl mutant alleles since their SIC1 proteolysis defect appears to be rather leaky (Bai et al., 1996) . We have shown, however, that recombinant SKP1 and CDC53 are required for CDC4/CDC34/CLN-dependent ubiquitination of SIC1 in crude insect cell lysates (Feldman et al., unpublished results) .
How Does CDC4 Promote the CDC34-dependent Ubiquitination of SICl? The sequence of CDC4 provides little clue as to how it promotes SIC1 multiubiquitination. CDC4 contains two recognizable motifs: an SKPl-binding domain known as an F-box and eight copies of the WD-40 repeat (Neer et al., 1994; Bai et al., 1996) . The crystal structure of the ,B-subunit of transducin reveals that its seven WD-40 repeats fold into a 13-propeller structure with seven blades evenly distributed about a central axis. This structure provides a platform for interaction of the 13-subunit with the a-and y-subunits of transducin (Wall et al., 1995; Lambright et al., 1996; Sondek et al., 1996) . Likewise, the WD-40 repeats of CDC4 may fold into a structure that promotes interactions between CDC4 and other ubiquitination factors or substrates.
Multiubiquitination of substrates that are degraded by the ubiquitin-dependent proteolytic pathway often requires E3 enzymes or accessory factors. Surprisingly, the two most well-studied E3s UBR1 (Bartel et al., 1990 ) and E6-AP (Huibregtse et al., 1993) are not homologous to each other or to CDC4. Furthermore, CDC4 lacks the conserved cysteine-containing motif that has been implicated in the ubiquitination-promoting activity of E6-AP and its homologs (Scheffner et al., 1995) . An understanding of the mechanism of action of CDC4 in the ubiquitination of SIC1 awaits a detailed dissection of this process.
SIC1 Ubiquitination
How Do CLNs Promote the Ubiquitination of SICl?
The accumulation of SIC1 is under cell cycle control. SIC1 begins to accumulate in telophase as the decline in CLB/CDC28 protein kinase activity enables an increase in SIC1 transcription due to nuclear translocation of the transcription factor SWI5 (Chau et al., 1989) . During early (pre-START) G1 phase, newly synthesized SIC1 is stable and can persist for long periods of time in cells arrested prior to START by mutations or nutrient starvation (Mendenhall et al., 1987; Schwob et al., 1994) . Upon traversal of START, active CLN/ CDC28 complexes are assembled and SIC1 is degraded shortly thereafter (Schneider et al., 1996) . Degradation of SIC1 depends upon CLN/CDC28 activity, as SIC1 persists in cdc28ts and CLN-depleted cells (Schwob et al., 1994; Schneider et al., 1996) . Whereas many of the processes downstream of START may be activated by the CLN/CDC28-dependent synthesis of new proteins, the results presented herein argue that CLN/CDC28 enables SIC1 destruction by a direct mechanism. CLN/CDC28 may promote SIC1 ubiquitination and degradation by directly phosphorylating SIC1 and rendering it susceptible to ubiquitination by a constitutively active CDC34 pathway, by activating an essential component of the CDC34 ubiquitination pathway, by inactivating an inhibitor of the CDC34 pathway, or by serving to bridge the assembly of SIC1 with ubiquitination factors such as CDC53 (Willems et al., 1996) . Experiments designed to distinguish conclusively between these four possibilities are currently underway.
How Does the G1-S Transition Work? The observations reported herein raise several questions about the mechanism of the G1-S transition in vivo. If CLN/CDC28 activity directly triggers SIC1 ubiquitination and subsequent proteolysis, does the rate of SIC1 destruction (and, conversely, the level of CLB5/CDC28 activity) mirror the rate of CLN accumulation or are there mechanisms that restrain SIC1 proteolysis until CLN/CDC28 activity exceeds a threshold? Since siclA cells enter S-phase precociously (Schneider et al., 1996) , it seems plausible that there exists a window of time in G1 phase between the accumulation of SBF-and MBF-promoted gene products, such as CLN1,2 and CLB5, and the degradation of SIC1 (Dirick et al., 1995) . If this is so, then how might SIC1 destruction be restrained in cells with active CLN/CDC28? Perhaps the ability of CLN/CDC28 to activate SIC1 destruction is opposed by a potent phosphatase; this possibility is supported by the observation that degradation of SIC1 upon reversal of the cdc34ts mutant block requires the continuous synthesis of CLN protein (Schneider et al., 1996) .
One factor that may contribute to the sharpness of the G1-S transition in vivo is the potential for positive feedback in the degradation of SIC1. Since multiubiquitination of SIC1 in vitro can be triggered by CLB2/ CDC28 ( Figure 3A , lane 4) and CLB5/CDC28 (Feldman, unpublished data), an initial burst of SIC1 destruction triggered by CLN/CDC28 would lead to the emergence of a small pool of liberated CLB5/ CDC28 complexes, which in turn could positively feed back to accelerate the rate of SIC1 ubiquitination and degradation. A detailed understanding of the relationship between CLN/CDC28 activity and the dynamics of the G1-S transition in vivo would be facilitated by the development of methods to monitor in real time the degradation of SIC1 in single cells.
Modular Organization of SIC1
The N-terminal ubiquitination domain of SIC1 contains a high density of potential CDC28 phosphorylation sites-there are seven (S/T)P dipeptides within the first 81 amino acids-and an N-terminal fragment containing the first 105 amino acids of SIC1 is a substrate for CLN2/CDC28-dependent phosphorylation.
Aside from potential phosphorylation sites, what other determinants within the N-terminal domain of SIC1 might target it for CDC34-dependent ubiquitination? SIC1 has been reported to contain PEST sequences located at amino acids 37-49 (PEST score -2.0), 115-141 (PEST score -2.1), and 198-212 (PEST score +2.0) (Nugroho and Mendenhall, 1994; Rechsteiner and Rogers, 1996) . PEST sequences are compositional elements that are rich in proline, glutamic acid, serine, and threonine; they are often found in unstable proteins. According to Rechsteiner and Rogers (1996) , however, only segments with scores above zero are normally considered as possible PEST regions. The three PEST elements within SIC1 are apparently not sufficient to direct its ubiquitination, since SIC1 AN37 is poorly ubiquitinated. Moreover, the SIC1 AC125 C-terminal truncation mutant, which lacks the only one of the three PEST regions with a positive score, is nevertheless a good substrate for CDC34-dependent ubiquitination. Since SIC1 AN27 is ubiquitinated with moderate efficiency (our unpublished observations) and SIC1 AN37 is a poor substrate, residues 28-37 provide an essential ubiquitination determinant. The nature of the signal contained in this segment is unclear at present. It is unlikely to be sufficient as a destruction signal however, since we have created mutations elsewhere in the N-terminal domain of SIC1 that eliminate ubiquitination (our unpublished results). A complete delineation of the sequence elements that specify SIC1 ubiquitination will require a more extensive mutagenic analysis of the N-terminal domain of SIC1.
Deletion analysis revealed that a C-terminal 126 amino acid segment of SIC1 is sufficient to bind CLB5/ CDC28 complexes and that the C-terminal 24 amino acids of SIC1 are absolutely essential for this interaction. It is interesting to note that this extreme C-terminal portion of SIC1 contains a copy of the "ZRXL" motif (KRRL), which has been implicated as a cyclin/ CDK2 recognition determinant . Mutant A-and B2-type cyclins that fail to bind CDC2 are poor substrates for ubiquitin-mediated proteolysis during anaphase (Stewart et al., 1994) . In contrast, a mutation (SIC1 AC24) that disrupts the interaction between SIC1 and CLB5/CDC28 has no discernible effect on SIC1 ubiquitination. Unlike cyclins, which are normally present in amounts substoichiometric with respect to CDC2, the concentration of SIC1 most likely exceeds that of CLB/CDC28 complexes in G1 cells. That SIC1 can be ubiquitinated regardless of whether it is bound to CLB5/CDC28 would ensure that the entire pool of SIC1 is synchronously destroyed at the G1-S transition, thereby preventing a pool of monomeric stable SIC1 from quenching the activity of CLB5/CDC28 complexes that had just been liberated by the destruction of bound SIC1 molecules.
